Phase III trial of beclometasone (SGX203) in paediatric patients with Crohn's disease
Status: Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 29 Jul 2019
Price : $35 *
At a glance
- Drugs Beclometasone (Primary)
- Indications Crohn's disease
- Focus Registrational; Therapeutic Use
- 29 Jul 2019 According to a Soligenix media release, the conduct of this trial is pending partnership and/or additional funding.
- 26 Jan 2016 According to a Soligenix media release, this trial is expected to be initiated during the first half of 2016.
- 14 Apr 2015 Primary results are expected to be available in the first half of 2017, according to a Soligenix media release.